本頁面由Tiger Trade Technology Pte. Ltd.提供服務

萊斯康製藥

1.72
+0.08004.88%
盤後1.71-0.0149-0.87%19:36 EDT
成交量:270.13萬
成交額:457.75萬
市值:7.29億
市盈率:-12.40
高:1.77
開:1.63
低:1.63
收:1.64
52周最高:1.83
52周最低:0.3200
股本:4.24億
流通股本:4.18億
量比:1.06
換手率:0.65%
股息:- -
股息率:- -
每股收益(TTM):-0.1387
每股收益(LYR):-0.1387
淨資產收益率:-39.72%
總資產收益率:-12.65%
市淨率:6.78
市盈率(LYR):-12.40

資料載入中...

公司資料

公司名字:
萊斯康製藥
交易所:
NASDAQ
成立時間:
1995
員工人數:
81
公司地址:
2445 Technology Forest Boulevard,11th Floor,The Woodlands,Texas,United States
郵編:
77381
電話:
傳真:
281 863 8088
簡介:
Lexicon Pharmaceuticals, Inc.是一家生物製藥公司,專註於研究並實現人類疾病在治療上的突破。通過基因敲除技術和先進的醫療技術綜合平台,該公司已經系統研究了小白鼠體內近5000個基因的生理和行為功能,且評估了由相應的人類基因作為潛在藥物靶標所編碼的蛋白質的效用,並且已經在活體(或活的有機體)內確定並驗證了100多個能很好地應用於藥物發現的靶標。對於那些被認定有很高藥用價值的靶標,其致力於對潛在新藥物的研製計劃。該公司於1995年7月7日在美國特拉華州成立,並於1995年9月開始營運。

董事

名稱
職位
Michael S. Exton
Chief Executive Officer and Director
Raymond Debbane
Chairman of the Board and Independent Director
Christopher J. Sobecki
Independent Director
Diane E. Sullivan
Independent Director
Ivan H. Cheung
Independent Director
Judith L. Swain
Independent Director
Philippe J. Amouyal
Independent Director
Samuel L. Barker
Independent Director

股東

名稱
職位
Michael S. Exton
Chief Executive Officer and Director
Brian T. Crum
Senior Vice President and General Counsel
Craig B. Granowitz
Senior Vice President and Chief Medical Officer
Lisa M. DeFrancesco
Senior Vice President, Investor Relations and Corporate Communications
Rachel Y. Martens
Senior Vice President, Partnerships and Corporate Strategy
Scott M. Coiante
Senior Vice President and Chief Financial Officer
Suma Gopinathan
Senior Vice President, Discovery
Wendy E. McDermott
Senior Vice President, Human Resources